{
    "2018-12-18": [
        [
            {
                "time": "2018-12-18",
                "original_text": "Lilly and Aduro Biotech Announce Research Collaboration and License Agreement to Develop Novel Immunotherapies",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Aduro Biotech",
                        "Research Collaboration",
                        "License Agreement",
                        "Immunotherapies"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-12-18",
                "original_text": "Teva Reports Positive Top-Line Data for Migraine Candidate",
                "features": {
                    "keywords": [
                        "Teva",
                        "Positive",
                        "Top-Line Data",
                        "Migraine Candidate"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-12-18",
                "original_text": "Lilly's Taltz Outshines Humira in Psoriatic Arthritis Study",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Taltz",
                        "Humira",
                        "Psoriatic Arthritis Study"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-12-18",
                "original_text": "iShares Core High Dividend ETF Experiences Big Inflow",
                "features": {
                    "keywords": [
                        "iShares",
                        "Core High Dividend ETF",
                        "Big Inflow"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance",
                        "ETFs"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-18",
                "original_text": "A Look At The Intrinsic Value Of Eli Lilly and Company (NYSE:LLY)",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Intrinsic Value",
                        "NYSE:LLY"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-12-18",
                "original_text": "Health Care Sector Update for 12/18/2018: LXRX, LLY, APHB, JNJ, PFE, ABT, MRK, APHB",
                "features": {
                    "keywords": [
                        "Health Care Sector",
                        "LXRX",
                        "LLY",
                        "APHB",
                        "JNJ",
                        "PFE",
                        "ABT",
                        "MRK"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-18",
                "original_text": "Lilly announces publication of analyses showing benefit of the addition of VerzenioÂ® (abemaciclib) in multiple subgroups of patients with advanced breast cancer identified as having a more concerning prognosis",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Verzenio",
                        "advanced breast cancer",
                        "subgroups",
                        "concerning prognosis"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "oncology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-12-18",
                "original_text": "Darling Dozen - 12 Healthcare IPOs That Didn't Disappoint",
                "features": {
                    "keywords": [
                        "Healthcare IPOs",
                        "Darling Dozen",
                        "Didn't Disappoint"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "IPOs"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-18",
                "original_text": "Elanco Initiates 2019 Guidance - Quick Facts",
                "features": {
                    "keywords": [
                        "Elanco",
                        "2019 Guidance",
                        "Quick Facts"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "veterinary"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}